AURKB and melanoma: In an independent, publicly available RNA sequencing dataset of patient-derived melanoma samples, AURKA, AURKB, and CDCA8 showed trends toward increased expression in patients who did not respond to anti-PD-1 therapy (progressive disease; supplementary figure. 10b).